valerates has been researched along with Hyperlipemia in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 28 (96.55) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (3.45) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| El-Awady, MS; Gameil, NM; Megahed, N; Sharawy, MH | 1 |
| Grundy, SM; Kesäniemi, YA | 1 |
| Nash, DT | 1 |
| Chin, B; Deutsch, S; Fenderson, RW; Menachemi, E; Samuel, P | 1 |
| Lewis, JE | 1 |
| Carlson, LA; Olsson, AG; Rössner, S; Walldius, G | 1 |
| Huttunen, JK; Nikkilä, EA; Ylikahri, R | 1 |
| Ghosh, P; Howard, AN | 1 |
| Neureuther, G; Schwandt, P; Weisweiler, P | 1 |
| Kuuisto, P; Mälkönen, M; Manninen, V; Salonen, J; Tuomilehto, J; Virtamo, J | 1 |
| Boberg, J; Hellsing, K; Lithell, H; Vessby, B; Werner, I | 1 |
| Eisalo, A; Manninen, V | 2 |
| Eisalo, A; Kuhlbäck, B; Mälkönen, M; Manninen, V | 1 |
| Irsigler, K; Lageder, H | 1 |
| Honorato, J; Masso, RM; Purroy, A | 1 |
| Bremner, WF; Clark, B; Corstorphine, C; Lawrie, TD; Third, JL | 1 |
| Maxwell, RE; Rodney, G; Uhlendorf, P | 1 |
| Rasi, VP; Torstila, I | 1 |
| Burton, R; Eisalo, A; Huunan-Seppälä, A; Manninen, V | 1 |
| de Salcedo, I; Gorringe, AL; Santos, JA; Silva, JL | 1 |
| Costa, D; Janus, ED; Lewis, B; Ononogbu, IC | 1 |
| Schwandt, P; Wilkening, J | 1 |
| Chang, DM; Fuh, MM; Jeng, CY; Shian, LR | 1 |
| Deans, K; Hartshorn, JC | 1 |
| Colli, S; Franceschini, G; Gianfranceschi, G; Maderna, P; Montanari, G; Sirtori, CR; Sirtori, M; Tremoli, E; Zoppi, F | 1 |
| Chen, JJ; Chou, TY; Han, HK; Ho, LT; Li, SH; Liu, YF; Perng, JC | 1 |
| Grundy, SM; Vega, GL | 1 |
14 trial(s) available for valerates and Hyperlipemia
| Article | Year |
|---|---|
Influence of gemfibrozil and clofibrate on metabolism of cholesterol and plasma triglycerides in man.
Topics: Adult; Aged; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Clinical Trials as Topic; Clofibrate; Gemfibrozil; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Pentanoic Acids; Steroids; Triglycerides; Valerates | 1984 |
Effect of gemfibrozil on serum lipids in man.
Topics: Adult; Aged; Blood Glucose; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Clinical Trials as Topic; Double-Blind Method; Female; Gemfibrozil; Humans; Hyperlipidemias; Hypolipidemic Agents; Insulin; Lipids; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Pentanoic Acids; Valerates | 1982 |
Long-term use of gemfibrozil (Lopid) in the treatment of dyslipidemia.
Topics: Adult; Aged; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Gemfibrozil; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Middle Aged; Pentanoic Acids; Triglycerides; Valerates | 1982 |
Effect of gemfibrozil on lipoprotein concentrations in different types of hyperlipoproteinaemia.
Topics: Cholesterol; Clinical Trials as Topic; Female; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipoproteins; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Time Factors; Triglycerides; Valerates; Xylenes | 1976 |
Gemfibrozil treatment: a comparison with clofibrate.
Topics: Cholesterol; Clinical Trials as Topic; Clofibrate; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipoproteins, LDL; Lipoproteins, VLDL; Time Factors; Triglycerides; Valerates; Xylenes | 1976 |
A clofibrate controlled trial of gemfibrozil in the treatment of hyperlipidaemias.
Topics: Arteriosclerosis; Cholesterol; Clinical Trials as Topic; Clofibrate; Female; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged; Time Factors; Triglycerides; Valerates; Xylenes | 1976 |
Gemfibrozil as a lipid lowering compound in hyperlipoproteinaemia. A placebo-controlled cross-over trial.
Topics: Adipose Tissue; Adult; Aged; Body Weight; Clinical Trials as Topic; Female; Fibrinogen; Glucose Tolerance Test; Humans; Hypercholesterolemia; Hyperlipidemias; Hypolipidemic Agents; Insulin; Lipoprotein Lipase; Lipoproteins; Male; Middle Aged; Placebos; Triglycerides; Valerates; Xylenes | 1976 |
Gemfibrozil and clofibrate in the treatment of hyperlipidaemias. A comparative trial.
Topics: Adult; Aged; Cholesterol; Clinical Trials as Topic; Clofibrate; Female; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged; Placebos; Time Factors; Triglycerides; Valerates; Xylenes | 1976 |
A long-term trial of gemfibrozil in the treatment of hyperlipidaemias.
Topics: Adult; Aged; Body Weight; Cholesterol; Clinical Trials as Topic; Female; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipoproteins; Male; Middle Aged; Time Factors; Triglycerides; Valerates; Xylenes | 1976 |
Hypolipidaemic action of gemfibrozil in adult nephrotics.
Topics: Adult; Aged; Cholesterol; Clinical Trials as Topic; Female; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipids; Lipoproteins; Male; Middle Aged; Nephrotic Syndrome; Time Factors; Valerates; Xylenes | 1976 |
Evaluation of increasing doses of gemfibrozil in hyperlipoproteinaemia.
Topics: Aged; Alkaline Phosphatase; Aspartate Aminotransferases; Cholesterol; Clinical Trials as Topic; Creatine Kinase; Humans; Hyperlipidemias; Hypolipidemic Agents; Middle Aged; Placebos; Time Factors; Triglycerides; Valerates; Xylenes | 1976 |
The use of gemfibrozil in the treatment of primary hyperlipoproteinaemia. Preliminary report.
Topics: Adult; Aged; Body Weight; Cholesterol; Clinical Trials as Topic; Female; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipoproteins; Male; Middle Aged; Time Factors; Triglycerides; Valerates; Xylenes | 1976 |
CI-719 in hyperlipoproteinaemia: interim data.
Topics: Adult; Cholesterol; Clinical Trials as Topic; Fatty Acids, Nonesterified; Female; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged; Time Factors; Triglycerides; Valerates; Xylenes | 1976 |
Gemfibrozil therapy in primary hypertriglyceridemia associated with coronary heart disease. Effects on metabolism of low-density lipoproteins.
Topics: Adult; Aged; Apolipoproteins B; Cholesterol, LDL; Coronary Disease; Gemfibrozil; Humans; Hyperlipidemias; Hyperlipoproteinemia Type IV; Hypolipidemic Agents; Lipoproteins, LDL; Male; Middle Aged; Pentanoic Acids; Triglycerides; Valerates | 1985 |
15 other study(ies) available for valerates and Hyperlipemia
| Article | Year |
|---|---|
The ergogenic supplement β-hydroxy-β-methylbutyrate (HMB) attenuates insulin resistance through suppressing GLUT-2 in rat liver.
Topics: Animals; Dietary Carbohydrates; Dietary Supplements; Endothelium, Vascular; Fructose; Gene Expression Regulation; Glucose Intolerance; Glucose Transporter Type 2; Hyperinsulinism; Hyperlipidemias; Insulin Resistance; Liver; Male; Non-alcoholic Fatty Liver Disease; Performance-Enhancing Substances; PPAR alpha; Random Allocation; Rats, Sprague-Dawley; Sterol Regulatory Element Binding Protein 1; TOR Serine-Threonine Kinases; Valerates; Vascular Resistance | 2016 |
Gemfibrozil in combination with other drugs for severe hyperlipidemia. Preliminary study comprising four cases.
Topics: Adult; Cholesterol; Cholestyramine Resin; Colestipol; Drug Therapy, Combination; Female; Gemfibrozil; Humans; Hyperlipidemias; Lipoproteins, HDL; Male; Middle Aged; Niacin; Pentanoic Acids; Probucol; Triglycerides; Valerates | 1983 |
Gemfibrozil for hyperlipidemia.
Topics: Cholesterol; Gemfibrozil; Humans; Hyperlipidemias; Hypolipidemic Agents; Pentanoic Acids; Triglycerides; Valerates | 1982 |
Gemfibrozil: effect on serum lipids, lipoproteins, postheparin plasma lipase activities and glucose tolerance in primary hypertriglyceridaemia.
Topics: Adolescent; Adult; Cholesterol; Depression, Chemical; Female; Glucose; Glucose Tolerance Test; Heparin; Humans; Hyperlipidemias; Hypolipidemic Agents; Insulin; Lipase; Lipids; Lipoproteins; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Time Factors; Triglycerides; Valerates; Xylenes | 1976 |
[The effect of gemfibrocil on serum lipids and lipoproteins in patients with hyperlipoproteinemia].
Topics: Humans; Hyperlipidemias; Lipids; Lipoproteins; Pentanoic Acids; Valerates; Xylenes | 1978 |
The hypolipidaemic effect of gemfibrozil (CI-719) in laboratory animals.
Topics: Animals; Cholesterol; Clofibrate; Depression, Chemical; Female; Haplorhini; Hyperlipidemias; Hypolipidemic Agents; Lipid Metabolism; Lipids; Liver; Macaca mulatta; Male; Mice; Organ Size; Rats; Time Factors; Triglycerides; Valerates; Xylenes | 1976 |
Effect of gemfibrozil upon platelet function and blood coagulation. Preliminary report.
Topics: Adult; Blood Cell Count; Blood Coagulation; Blood Platelets; Female; Humans; Hyperlipidemias; Hypolipidemic Agents; In Vitro Techniques; Lipids; Male; Middle Aged; Platelet Adhesiveness; Platelet Aggregation; Valerates; Xylenes | 1976 |
Extrinsic factors affecting the response to gemfibrozil.
Topics: Adult; Age Factors; Cholesterol; Diet; Female; Humans; Hyperlipidemias; Hypolipidemic Agents; Iron; Male; Seasons; Sex Factors; Time Factors; Triglycerides; Valerates; Xylenes | 1976 |
Gemfibrozil in a group of diabetics.
Topics: Aged; Blood Glucose; Blood Pressure; Cholesterol; Diabetes Complications; Diabetes Mellitus; Diabetic Retinopathy; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipids; Lipoproteins; Middle Aged; Ophthalmoscopy; Placebos; Time Factors; Triglycerides; Valerates; Xylenes | 1976 |
The evaluation of lipoprotein changes during gemfibrozil treatment.
Topics: Cholesterol; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipoproteins; Triglycerides; Valerates; Xylenes | 1976 |
Summary of present data from a clinical trial of CI-719.
Topics: Humans; Hyperlipidemias; Hypolipidemic Agents; Lipoproteins; Time Factors; Triglycerides; Valerates; Xylenes | 1976 |
The hypolipidemic effect of gemfibrozil on hyperlipidemia in patients with non-insulin-dependent diabetes mellitus.
Topics: Aged; Cholesterol, HDL; Diabetes Mellitus, Type 2; Female; Gemfibrozil; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipids; Male; Middle Aged; Pentanoic Acids; Valerates | 1986 |
Treatment of hyperlipidemia with gemfibrozil.
Topics: Gemfibrozil; Humans; Hyperlipidemias; Hypolipidemic Agents; Pentanoic Acids; Valerates | 1987 |
Effects of gemfibrozil on plasma lipoprotein-apolipoprotein distribution and platelet reactivity in patients with hypertriglyceridemia.
Topics: Adult; Aged; Apolipoproteins; Cholesterol; Cholesterol, HDL; Cholesterol, VLDL; Female; Gemfibrozil; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipoproteins; Lipoproteins, VLDL; Male; Middle Aged; Pentanoic Acids; Platelet Aggregation; Triglycerides; Valerates | 1987 |
Gemfibrozil has antilipemic effects on diabetic patients with hyperlipidemia.
Topics: Adult; Aged; Diabetes Mellitus, Type 2; Drug Evaluation; Female; Gemfibrozil; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged; Pentanoic Acids; Valerates | 1987 |